(Q40359887)

19 September 2017

title

Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice (English)

1 reference

19 September 2017

1 reference

Chuan Li

1

1 reference

19 September 2017

Feng Liu

2

1 reference

19 September 2017

Mifang Liang

3

1 reference

19 September 2017

Quanfu Zhang

4

1 reference

19 September 2017

Xiaofang Wang

5

1 reference

19 September 2017

Tao Wang

6

1 reference

19 September 2017

Jiandong Li

7

1 reference

19 September 2017

Dexin Li

8

1 reference

19 September 2017

language of work or name

English

0 references

publication date

28 April 2010

1 reference

19 September 2017

1 reference

19 September 2017

volume

28

1 reference

19 September 2017

issue

26

1 reference

19 September 2017

page(s)

4294-4300

1 reference

Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Hantaviruses: A Global Disease Problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Virus-like particles as HIV-1 vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Vaccination strategies for the treatment and prevention of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Virus-like particles: a new family of delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Antigenic Difference Between Viral Strains Causing Classical and Mild Types of Epidemic Hemorrhagic Fever with Renal Syndrome in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Antigenic and molecular characterization of hantavirus isolates from China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Human recombinant neutralizing antibodies against hantaan virus G2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Hantavirus infections and their prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Vaccines against hantaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Papillomavirus capsid binding and uptake by cells from different tissues and species.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.04.025

1 reference

19 September 2017

1 reference